Tapewire

Nasdaq · USD

INDV

Indivior Pharmaceuticals, Inc.

Export transactions ↓
Tapewire entity
4040
SEC CIK
0001625297
Parsed reports
52

Last 12 months

Inside the activity.

10 purchase rows · 3 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202650
Feb 202600
Mar 202630
Apr 202600
May 202600
Jun 202602
Jul 202601
Aug 202620
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
January 26, 2026 Filed Jan 28, 2026 21:09 UTC GrantCommon Stock 3,722 $0.00 $0.00
Disclosure

SEC source: 0001257599-26-000006 · wk-form4_1769634538.xml · nonDerivative · entry 1

NINIVAGGI DANIEL A · CIK 0001257599 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,645

F1 · shares: Reflects a grant of Restricted Stock Units (RSUs). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs vest on the day immediately preceding the date of the first annual meeting of the Issuer's stockholders following the date of grant, subject to the Reporting Person's continued service to the Issuer on the vesting date.

Read SEC document
January 26, 2026 Filed Jan 28, 2026 21:08 UTC GrantCommon Stock 3,722 $0.00 $0.00
Disclosure

SEC source: 0001487937-26-000006 · wk-form4_1769634491.xml · nonDerivative · entry 1

Stejbach Mark · CIK 0001487937 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,569

F1 · shares: Reflects a grant of Restricted Stock Units (RSUs). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs vest on the day immediately preceding the date of the first annual meeting of the Issuer's stockholders following the date of grant, subject to the Reporting Person's continued service to the Issuer on the vesting date.

Read SEC document
January 26, 2026 Filed Jan 28, 2026 21:07 UTC GrantCommon Stock 3,722 $0.00 $0.00
Disclosure

SEC source: 0001715258-26-000004 · wk-form4_1769634439.xml · nonDerivative · entry 1

Thompson Juliet · CIK 0001715258 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,572

F1 · shares: Reflects a grant of Restricted Stock Units (RSUs). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs vest on the day immediately preceding the date of the first annual meeting of the Issuer's stockholders following the date of grant, subject to the Reporting Person's continued service to the Issuer on the vesting date.

Read SEC document
January 26, 2026 Filed Jan 28, 2026 21:05 UTC GrantCommon Stock 3,722 $0.00 $0.00
Disclosure

SEC source: 0002014900-26-000006 · wk-form4_1769634350.xml · nonDerivative · entry 1

Humphreys Keith · CIK 0002014900 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,524

F1 · shares: Reflects a grant of Restricted Stock Units (RSUs). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs vest on the day immediately preceding the date of the first annual meeting of the Issuer's stockholders following the date of grant, subject to the Reporting Person's continued service to the Issuer on the vesting date.

Read SEC document
January 05, 2026 Filed Jan 7, 2026 18:50 UTC PurchaseOrdinary Shares 775 $35.39 $27,429.27
Disclosure

SEC source: 0002014900-26-000004 · wk-form4_1767811835.xml · nonDerivative · entry 1

Humphreys Keith · CIK 0002014900 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 5,802

F1 · kind: Securities acquired pursuant to the director's participation in a Non-Executive Director Purchase Plan to receive a portion of the fees received for service as a director in stock in lieu of cash.

Read SEC document
January 05, 2026 Filed Jan 7, 2026 18:51 UTC
Ryan BarbaraDirector
PurchaseOrdinary Shares 775 $35.39 $27,429.27
Disclosure

SEC source: 0001827169-26-000004 · wk-form4_1767811905.xml · nonDerivative · entry 1

Ryan Barbara · CIK 0001827169 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,963

F1 · kind: Securities acquired pursuant to the director's participation in a Non-Executive Director Purchase Plan to receive a portion of the fees received for service as a director in stock in lieu of cash.

Read SEC document
January 05, 2026 Filed Jan 7, 2026 18:49 UTC PurchaseOrdinary Shares 775 $35.39 $27,429.27
Disclosure

SEC source: 0001257599-26-000004 · wk-form4_1767811770.xml · nonDerivative · entry 1

NINIVAGGI DANIEL A · CIK 0001257599 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 16,923

F1 · kind: Securities acquired pursuant to the director's participation in a Non-Executive Director Purchase Plan to receive a portion of the fees received for service as a director in stock in lieu of cash.

Read SEC document
January 05, 2026 Filed Jan 7, 2026 18:48 UTC PurchaseOrdinary Shares 775 $35.39 $27,429.27
Disclosure

SEC source: 0001487937-26-000004 · wk-form4_1767811690.xml · nonDerivative · entry 1

Stejbach Mark · CIK 0001487937 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 16,847

F1 · kind: Securities acquired pursuant to the director's participation in a Non-Executive Director Purchase Plan to receive a portion of the fees received for service as a director in stock in lieu of cash.

Read SEC document
January 05, 2026 Filed Jan 7, 2026 18:47 UTC PurchaseOrdinary Shares 1,771 $35.39 $62,680.29
Disclosure

SEC source: 0001789507-26-000004 · wk-form4_1767811617.xml · nonDerivative · entry 1

Wheadon David E. · CIK 0001789507 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 14,395

F1 · kind: Securities acquired pursuant to the director's participation in a Non-Executive Director Purchase Plan to receive a portion of the fees received for service as a director in stock in lieu of cash.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.